Robuta

Sponsor of the Day: Jerkmate
https://variational.ai/news/use-case/variational-ai-life-chemicals-join-forces-to-discover-selective-dual-egfr-fgfr1-inhibitors-using-generative-ai/ Variational AI & Life Chemicals join forces to discover selective dual EGFR/FGFR1 inhibitors using... Following their successful 2022 collaboration, which targeted the SARS-CoV-2 main protease, Variational AI and Life Chemicals have partnered for a second time... variational aijoin forceslifechemicalsdiscover https://www.jci.org/articles/view/189152/pdf JCI - Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma jci mutated fgfr1high risk neuroblastomaoncogenic drivertherapeutic target https://www.jci.org/articles/view/189152 JCI - Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma jci mutated fgfr1high risk neuroblastomaoncogenic drivertherapeutic target https://www.jci.org/articles/view/189152/figure/1 JCI - Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma jci mutated fgfr1high risk neuroblastomaoncogenic drivertherapeutic target https://www.ncbi.nlm.nih.gov/books/NBK349073/ FGFR1-Related Hartsfield Syndrome - GeneReviews® - NCBI Bookshelf FGFR1-related Hartsfield syndrome comprises two core features: holoprosencephaly (HPE) spectrum disorder and ectrodactyly spectrum disorder. ncbi bookshelffgfr1relatedhartsfieldsyndrome